Drugs News and Research

RSS

FDA approves first extended adjuvant therapy to lower risk of breast cancer recurrence

The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer.

18 Jul 2017

GPs prescribing anticoagulants to AF patients against official safety advice, study shows

A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

17 Jul 2017

New bioanalytical method could pave way for personalized drug therapy

Personalized drug therapy, adjusting the dose, dosage intervals, and the duration of treatment to fit individual patients' needs, are getting more and more important.

17 Jul 2017

NIH researchers show how investigational drug works against rare, fatal genetic disease

Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).

17 Jul 2017

New optical clearing method helps analyze 3D structure of dangerous blood clots

A new technique that makes blood clots optically clear is allowing researchers to use powerful optical microscopy techniques to study the 3D structure of dangerous clots for the first time.

17 Jul 2017

Existing drugs could offer new way to treat severe inflammatory skin conditions

Existing medicines could offer a new way to treat inflammatory skin conditions, researchers at Melbourne's Walter and Eliza Hall Institute and the Royal Melbourne Hospital have revealed.

17 Jul 2017

Analysis: Senate’s latest health blueprint cuts costs at the expense of chronically ill

The latest Senate health proposal reins in costs by effectively splitting the individual insurance market, with healthy people diverted into stripped-down plans and chronically ill individuals left with pricey and potentially out-of-reach options, insurance analysts said.

17 Jul 2017

Combining care program with drug reduces damaging effects of Alzheimer's disease

Combining a specific care management program with a commonly-prescribed drug for Alzheimer's disease multiplies the medication's ability to improve daily function by about 7.5 times, stalling some of the disease's most damaging effects.

17 Jul 2017

Sartorius Stedim Biotech introduces complete range of chemistry testing services

Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industry, announced the launch of a full range of chemistry testing services. Offered by its subsidiary Sartorius Stedim BioOutsource, they characterize the physicochemical properties and structural attributes of therapeutic monoclonal antibodies (mAbs).

From Sartorius 17 Jul 2017

Nemaura Pharma selected as finalist in Medilink UK industry awards

Nemaura Pharma, the fast-growing UK medical technology company, is a finalist in the Medilink UK industry awards having received the Medilink East Midlands Innovation award for its unique transdermal drug delivery technologies.

17 Jul 2017

Southampton researchers find new approach to reverse treatment resistance in lymphoma patients

Researchers from the University of Southampton have identified why some people may become resistant to monoclonal antibodies, a common type of immunotherapy used in lymphoma treatment.

17 Jul 2017

MGH researchers identify novel mechanism behind resistance to angiogenesis inhibitors

A Massachusetts General Hospital research team has identified a novel mechanism behind resistance to angiogenesis inhibitors - drugs that fight cancer by suppressing the formation of new blood vessels.

14 Jul 2017

UW-Madison researchers jump major hurdle on path toward wider use of stem cells

Since highly versatile human stem cells were discovered at the University of Wisconsin-Madison nearly 20 years ago, their path to the market and clinic has been slowed by a range of complications.

14 Jul 2017

Mayo Clinic and nference launch startup to develop drugs for rare diseases

Today, Mayo Clinic and nference launch a startup company for drug development that will be powered by clinical expertise and artificial intelligence (AI).

14 Jul 2017

Preemies treated with caffeine have better lung function in mid-childhood, study finds

Premature babies treated with caffeine have better lung function in mid-childhood than preemies not treated with caffeine, according to a randomized controlled trial published in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

14 Jul 2017

FDA panel recommends new breakthrough gene therapy for B-cell acute lymphoblastic leukemia (ALL)

A Food and Drug Administration (FDA) panel created history by recommending a gene therapy for patients with cancer. In this therapy the patient’s own genes would be modified to fight the cancer cells. The patient’s cells which are thus altered to treat the cancer would thus be termed as “living drugs” as they act as soldiers to treat the cancer. These cells boost up the immune system and help the body fight the cancer.

14 Jul 2017

Drugs News and Research

FDA approves first extended adjuvant therapy to lower risk of breast cancer recurrence

GPs prescribing anticoagulants to AF patients against official safety advice, study shows

New bioanalytical method could pave way for personalized drug therapy

NIH researchers show how investigational drug works against rare, fatal genetic disease

New optical clearing method helps analyze 3D structure of dangerous blood clots

Existing drugs could offer new way to treat severe inflammatory skin conditions

Analysis: Senate’s latest health blueprint cuts costs at the expense of chronically ill

Combining care program with drug reduces damaging effects of Alzheimer's disease

Sartorius Stedim Biotech introduces complete range of chemistry testing services

Nemaura Pharma selected as finalist in Medilink UK industry awards

Southampton researchers find new approach to reverse treatment resistance in lymphoma patients

MGH researchers identify novel mechanism behind resistance to angiogenesis inhibitors

UW-Madison researchers jump major hurdle on path toward wider use of stem cells

Mayo Clinic and nference launch startup to develop drugs for rare diseases

Preemies treated with caffeine have better lung function in mid-childhood, study finds

FDA panel recommends new breakthrough gene therapy for B-cell acute lymphoblastic leukemia (ALL)

Daily tomato consumption may cut skin cancer by half, mouse study shows

Transgender health care targeted in crusade to undo ACA

Ground-breaking new breast cancer drugs have manageable toxicity profile for most patients

Scientists positively influence immune response in viral and bacterial co-infection

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News